Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients

INTRODUCTION: Immunocompromised patients infected with influenza exhibit prolonged viral shedding and higher risk of resistance. Optimized treatment strategies are needed to reduce the risk of antiviral resistance. This phase IIIb, randomized, double-blind study (NCT00545532) evaluated conventional-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitha, Essack, Krivan, Gergely, Jacobs, Frederique, Nagler, Arnon, Alrabaa, Sally, Mykietiuk, Analia, Kenwright, Andrew, Le Pogam, Sophie, Clinch, Barry, Vareikiene, Loreta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856247/
https://www.ncbi.nlm.nih.gov/pubmed/31667696
http://dx.doi.org/10.1007/s40121-019-00271-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856247/
https://www.ncbi.nlm.nih.gov/pubmed/31667696
http://dx.doi.org/10.1007/s40121-019-00271-8

Ejemplares similares